CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 136 enrolled
Drug / intervention
Karajishi Contour Investigational BG Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02041286
NCT02041286N/ACompleted
CompareCT.gov

User Performance of the Karajishi Contour Blood Glucose Monitoring System

Ascensia Diabetes Care·interventional·Posted Jan 22, 2014·Updated Feb 29, 2016

In Brief

A clinical study evaluating Karajishi Contour Investigational BG Monitoring System for Diabetes. Completed, enrolled 136 participants across 2 sites.

Detailed Summary

The purpose of this study is to determine if subjects who have diabetes can operate the Investigational Blood Glucose Monitoring System (BGMS) without training and obtain valid glucose results.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedJan 22, 2014
Enrollment StartJan 1, 2014
Primary CompletionJan 1, 2014
TodayJul 2, 2026
Enrollment to primary: 0 daysPosted 12.4 years ago

Interventions

Karajishi Contour Investigational BG Monitoring Systemdevice

Subjects with diabetes perform self Blood Glucose (BG) tests with capillary fingerstick and palm blood using the Karajishi Contour Investigational BG Monitoring System with no training. All BG results are compared to reference method results obtained from subject capillary plasma. Also, study staff test subject venous blood and BG results are compared to reference method results obtained from subject venous plasma.